Monocarboxylate transporter (MCT)-1 is up-regulated by PPARα

Biochimica et Biophysica Acta - General Subjects

Volumn 1780, Issue 6, 2008, Pages 899-904

  König, Bettina ^a   Koch, Alexander ^a   Giggel, Karen ^a   Dordschbal, Batsuch ^a   Eder, Klaus ^a   Stangl, Gabriele I ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Monocarboxylate transporter 1; Peroxisome proliferator activated receptor (PPAR) ; PPAR null mice

Indexed keywords

CLOFIBRATE; KETONE BODY; MESSENGER RNA; MONOCARBOXYLATE TRANSPORTER 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIRINIXIC ACID; TROGLITAZONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; ENZYME ACTIVATION; FEMALE; HEPATOMA CELL; KIDNEY; LIVER; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; SMALL INTESTINE; UPREGULATION;

ANIMALS; ANTILIPEMIC AGENTS; CLOFIBRATE; FASTING; FATTY ACIDS; KETONE BODIES; MALE; MICE; MONOCARBOXYLIC ACID TRANSPORTERS; ORGAN SPECIFICITY; OXIDATION-REDUCTION; PEROXISOME PROLIFERATORS; PPAR ALPHA; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SYMPORTERS; UP-REGULATION;

MUS; RATTUS;

EID: 43049159570     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2008.03.002     Document Type: Article

References (36)

1. Desvergne B., and Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20 (1999) 649-688
2. Hihi A.K., Michalik L., and Wahli W. PPARs: transcriptional effectors of fatty acids and their derivatives. Cell. Mol. Life Sci. 59 (2002) 790-798
3. Mandard S., Müller M., and Kersten S. Peroxisome proliferator-activated receptor alpha target genes. Cell. Mol. Life Sci. 61 (2004) 393-416
4. Rodriguez J.C., Gil-Gomez G., Hegardt F.G., and Haro D. Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids. J. Biol. Chem. 269 (1994) 18767-18772
5. Pollay M., and Stevens F.A. Starvation-induced changes in transport of ketone bodies across the blood-brain barrier. J. Neurosci. Res. 5 (1980) 163-172
6. Finn P.F., and Dice J.F. Proteolytic and lipolytic responses to starvation. Nutrition 22 (2006) 830-844
7. Faria M.H., Muniz L.R., and Vasconcelos P.R. Ketone bodies metabolism during ischemic and reperfusion brain injuries following bilateral occlusion of common carotid arteries in rats. Acta Cir. Bras. 22 (2007) 125-129
8. Koppaka S.S., Puchowicz M.A., LaManna J.C., and Gatica J.E. Effect of alternate energy substrates on mammalian brain metabolism during ischemic events. Adv. Exp. Med. Biol. 614 (2008) 361-370
9. Mitchell G.A., Kassovska-Bratinova S., Boukaftane Y., Robert M.F., Wang S.P., Ashmarina L., Lambert M., Lapierre P., and Potier E. Medical aspects of ketone body metabolism. Clin. Invest. Med. 18 (1995) 193-216
10. Hawkins R.A., Williamson D.H., and Krebs H.A. Ketone-body utilization by adult and suckling rat brain in vivo. Biochem. J. 122 (1971) 13-18
11. Gjedde A., and Crone C. Induction processes in blood-brain transfer of ketone bodies during starvation. Am. J. Physiol. 229 (1975) 1165-1169
12. Halestrap A.P., and Meredith D. The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflügers Arch. 447 (2004) 619-628
13. Halestrap A.P., and Price N.T. The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem. J. 343 (1999) 281-299
14. Poole R.C., and Halestrap A.P. Identification and partial purification of the erythrocyte l-lactate transporter. Biochem. J. 283 (1992) 855-862
15. Enerson B.E., and Drewes L.R. Molecular features, regulation, and function of monocarboxylate transporters: implications for drug delivery. J. Pharm. Sci. 92 (2003) 1531-1544
16. Senekeo-Effenberger K., Chen S., Brace-Sinnokrak E., Bonzo J.A., Yueh M.F., Argikar U., Kaeding J., Trottier J., Remmel R.P., Ritter J.K., Barbier O., and Tukey R.H. Expression of the human UGT1 locus in transgenic mice by 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid (WY-14643) and implications on drug metabolism through peroxisome proliferator-activated receptor alpha activation. Drug Metab. Dispos 35 (2007) 419-427
17. Mossman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
18. König B., and Eder K. Differential action of 13-HPODE on PPARalpha downstream genes in rat Fao and human HepG2 hepatoma cell lines. J. Nutr. Biochem. 17 (2006) 410-418
19. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29 (2001) e45
20. Kersten S., Seydoux J., Peters J.M., Gonzalez F.J., Desvergne B., and Wahli W. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J. Clin. Invest. 103 (1999) 1489-1498
21. Sugiyama H., Yamada J., and Suga T. Effects of testosterone, hypophysectomy and growth hormone treatment on clofibrate induction of peroxisomal beta-oxidation in female rat liver. Biochem. Pharmacol. 47 (1994) 918-921
22. Jalouli M., Carlsson L., Ameen C., Linden D., Ljungberg A., Michalik L., Eden S., Wahli W., and Oscarsson J. Sex difference in hepatic peroxisome proliferator-activated receptor alpha expression: influence of pituitary and gonadal hormones. Endocrinology 144 (2003) 101-109
23. Krey G., Braissant O., L'Horset F., Kalkhoven E., Perroud M., Parker M.G., and Wahli W. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11 (1997) 779-791
24. Forman B.M., Chen J., and Evans R.M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 4312-4317
25. Berger J., Bailey P., Biswas C., Cullinan C.A., Doebber T.W., Hayes N.S., Saperstein R., Smith R.G., and Leibowitz M.D. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice. Endocrinology 137 (1996) 4189-4195
26. Escher P., Braissant O., Basu-Modak S., Michalik L., Wahli W., and Desvergne B. Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding. Endocrinology 142 (2001) 4195-4202
27. Bünger M., van den Bosch H.M., van der Meijde J., Kersten S., Hooiveld G.J., and Muller M. Genome-wide analysis of PPARalpha activation in murine small intestine. Physiol. Genomics 30 (2007) 192-204
28. Kliewer S.A., Forman B.M., Blumberg B., Ong E.S., Borgmeyer U., Mangelsdorf D.J., Umesono K., and Evans R.M. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 7355-7359
29. Cuff M.A., Lambert D.W., and Shirazi-Beechey S.P. Substrate-induced regulation of the human colonic monocarboxylate transporter, MCT1. J. Physiol. 539 (2002) 361-371
30. Leino R.L., Gerhart D.Z., Duelli R., Enerson B.E., and Drewes L.R. Diet-induced ketosis increases monocarboxylate transporter (MCT1) levels in rat brain. Neurochem. Int. 38 (2001) 519-527
31. Borthakur A., Saksena S., Gill R.K., Alrefai W.A., Ramaswamy K., and Dudeja P.K. Regulation of monocarboxylate transporter 1 (MCT1) promoter by butyrate in human intestinal epithelial cells: involvement of NF-kappaB pathway. J. Cell. Biochem. (2007) (Electronic publication ahead of print).
32. Palmer C.N., Hsu M.H., Griffin H.J., and Johnson E.F. Novel sequence determinants in peroxisome proliferator signaling. J. Biol. Chem. 270 (1995) 16114-16121
33. Zandbergen F., Mandard S., Escher P., Tan N.S., Patsouris D., Jatkoe T., Rojas-Caro S., Madore S., Wahli W., Tafuri S., Muller M., and Kersten S. The G0/G1 switch gene 2 is a novel PPAR target gene. Biochem. J. 392 (2005) 313-324
34. Stienstra R., Mandard S., Tan N.S., Wahli W., Trautwein C., Richardson T.A., Lichtenauer-Kaligis E., Kersten S., and Muller M. The Interleukin-1 receptor antagonist is a direct target gene of PPARalpha in liver. J. Hepatol. 46 (2007) 869-877
35. Inagaki T., Dutchak P., Zhao G., Ding X., Gautron L., Parameswara V., Li Y., Goetz R., Mohammadi M., Esser V., Elmquist J.K., Gerard R.D., Burgess S.C., Hammer R.E., Mangelsdorf D.J., and Kliewer S.A. Endocrine rf 21. Cell Metab. 5 (2007) 415-425
36. Thwaites D.T., and Anderson C.M. H+-coupled nutrient, micronutrient and drug transporters in the mammalian small intestine. Exp. Physiol. 92 (2007) 603-619